Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction

Human Reproduction

Volumn 15, Issue 5, 2000, Pages 1003-1008

  Westergaard, Lars G ^a   Laursen, Steen B ^a   Yding Andersen, Claus ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Assisted reproduction treatment; Early pregnancy loss; Luteinizing hormone; Profound suppression

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HORMONAL ABORTION; HORMONE INHIBITION; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY DISORDER; RETROSPECTIVE STUDY;

FALLOPIA;

EID: 0034013857     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.5.1003     Document Type: Article

References (18)

1. Agrawal, R., Conway, G.S. and Engmann, L. (1998) Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization. Gynecol. Endocrinol., 12, 9-15.
2. Apter, D., Cacciatore, B., Alfthan, H. et al. (1989) Serum luteinizing hormone concentrations increase 100-fold in females from 7 years of age to adulthood, as measured by time-resolved immunofluorometric assay. J. Clin. Endocrinol. Metab., 68, 53-57.
3. Balasch, J., Miro, F. and Burzaco, I. (1995) The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum. Reprod., 10, 1678-1683.
4. Chappel, S. and Howles, C. (1991) Reevaluation of the roles of luteinizing hormone and follicle stimulating hormone in the ovulatory process. Hum. Reprod., 6, 1206-1212.
5. Fleming, R., Chung, C.C., Yates, R.W.S. et al. (1996) Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum. Reprod., 11, 1854-1858.
6. Fleming, R., Lloyd, F., Herbert, M. et al. (1998) Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum. Reprod., 13, 1788-1792.
7. Gordon, U.D. (1999) Effects of different menotropin preparations for assisted reproduction in hypogonadotropic hypogonadism. In Filicori, M. (ed.), The Role of Luteinizing Hormone in Folliculogenesis and Ovulation Induction. Monduzzi Editore, Bologna, 1999, pp. 135-143.
8. Kelly, E.E. and Nebiolo, L. (1999) Recombinant FSH therapy alone (Gonal-F) versus combination therapy (Gonal-F + Lhadi, R-HLH) in patients down-regulated with low dose luteal GnRH agonist protocol. Preliminary results. 11th World Congress on In vitro Fertilization and Human Reproductive Genetics. Abstract S-003.
9. Loumaye, E., Engrand, P., Howles, C. et al. (1997) Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil. Steril., 67, 889-899.
10. The Ganirelix dose-finding study group (1998) A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum. Reprod., 13, 3023-3031.
11. Shoham, Z. (1999) Effects of different menotropin preparations for ovulation induction in hypogonadotropic women. In Filicori, M. (ed.), The Role of Luteinizing in Folliculogenesis and Ovulation Induction. Monduzzi Editore, Bologna, 1999, pp. 105-114.
12. Shoham, Z., Balen, A. and Patel, A. (1991) Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil. Steril., 56, 1048-1053.
13. Tesarik, J. and Mendoza, C. (1995) Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab., 80, 1438-1443.
14. Westergaard, L.G., Erb, K., Laursen, S.B. et al. (1996) The effect of human menopausal gonadotrophin and purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum. Reprod., 11, 1209-1213.
15. Weston, A.M., Zelinski-Wooten, M.B., Hutchison, J.S. et al. (1996) Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Hum. Reprod., 11, 608-613.
16. Wu, T.C., Wang, L. and Wan, Y.J. (1993) Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil. Steril., 59, 54-59.
17. Yding Andersen, C. (1993) Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J. Clin. Endocrinol. Metab., 77, 1227-1234.
18. Yoshimura, Y. and Wallach, E.E. (1987) Studies on the mechanism(s) of mammalian ovulation. Fertil. Steril., 47, 22-34.